VMD Sciences Expands Veterinary Pharmaceutical Supply Solutions to Address Drug Shortages and Emerging Disease Threats in the United States

VMD Sciences has expanded its veterinary pharmaceutical supply solutions to address drug shortages and emerging disease threats in the U.S. The company is providing veterinarians with access to critical therapeutics, including an EU-approved alternative for equine colic therapies, amid a shortage of Buscopan®. Additionally, VMDS is addressing the rise of infectious diseases like Theileriosis, supporting veterinarians with compliant pathways to import necessary medications from abroad. The initiative aims to ensure continuity of care and maintain high standards of regulatory compliance.